These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Ventricular tachycardia and ventricular fibrillation following myocardial infarct: determinants of prognosis and disease course]. Trappe HJ, Brugada P, Talajic M, Lezaun R, Wellens HJ. Z Kardiol; 1988 Nov; 77(11):687-95. PubMed ID: 3213136 [Abstract] [Full Text] [Related]
8. [Prognosis and management of patients with tachycardial heart arrhythmia ]. Steinbach K. Wien Med Wochenschr; 1984 Oct 31; 134(19-20):425-6. PubMed ID: 6516418 [Abstract] [Full Text] [Related]
9. New methods for treating malignant ventricular arrhythmia. Chesnie B. J La State Med Soc; 1983 Apr 31; 135(4):31-4, 39-40. PubMed ID: 6553064 [No Abstract] [Full Text] [Related]
10. [Programmed ventricular stimulation in detecting malignant ventricular arrhythmia following myocardial infarct]. Klein H. Internist (Berl); 1987 Mar 31; 28(3):151-8. PubMed ID: 3294721 [No Abstract] [Full Text] [Related]
11. [Value and limitations of electropharmacological tests in the selection of anti-arrhythmic therapy in malignant ventricular tachyarrhythmia]. Klein H. Cardiologia; 1985 Jul 31; 30(7):487-92. PubMed ID: 3834995 [No Abstract] [Full Text] [Related]
12. [Etiologies of electric storm]. Dorian P. Arch Mal Coeur Vaiss; 1997 Apr 31; 90 Spec No 1():27-31. PubMed ID: 9238454 [Abstract] [Full Text] [Related]
13. [Control of antiarrhythmic drug efficacy in patients with chronic recurrent ventricular tachycardia by electrical stimulation (author's transl)]. Breithardt G, Seipel L, Haerten K, Abendroth RR, Loogen F. Z Kardiol; 1979 Nov 31; 68(11):725-30. PubMed ID: 543190 [No Abstract] [Full Text] [Related]
16. Antiarrhythmic therapy for the prevention of sudden cardiac death. Cairns J, Kerr C, Teo K. Can J Cardiol; 2000 Jun 31; 16 Suppl C():29C-33C. PubMed ID: 10887276 [No Abstract] [Full Text] [Related]
17. [Programmed electric stimulation following acute myocardial infarct. Significance of stimulation timing]. Costard A, Schlüter M, Kunze KP, Wolf U, Kuck KH. Z Kardiol; 1986 Oct 31; 75(10):589-97. PubMed ID: 3788250 [Abstract] [Full Text] [Related]
18. [Prognostic value of the late potentials of ventricular activation in coronary disease]. Zimmermann M, Adamec R, Simonin P, Richez J. Schweiz Med Wochenschr; 1984 Nov 10; 114(45):1611-4. PubMed ID: 6515363 [Abstract] [Full Text] [Related]
19. Identification of patients at risk for arrhythmic death: role of Holter ECG recording. Bigger JT, Coromilas J. Cardiovasc Clin; 1985 Nov 10; 15(3):131-43. PubMed ID: 2421901 [No Abstract] [Full Text] [Related]
20. Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction. Rodriguez LM, Smeets J, O'Hara GE, Geelen P, Brugada P, Wellens HJ. Am J Cardiol; 1992 Jun 01; 69(17):1403-6. PubMed ID: 1590227 [Abstract] [Full Text] [Related] Page: [Next] [New Search]